Paper8739655
The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.
Harvey HA and 1 other. Support Care Cancer, 1996. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience. Papers, record 8739655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8739655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bone Neoplasms | Major topic |
| Clinical Trials as Topic | Major topic |
| Diphosphonates | Major topic |
| Bone Resorption | |
| Breast Neoplasms | |
| Clinical Trials, Phase I as Topic | |
| Clinical Trials, Phase III as Topic | |
| Female | |
| Fractures, Spontaneous | |
| Humans | |
| Hypercalcemia | |
| Injections, Intravenous | |
| Male | |
| Multiple Myeloma | |
| Osteoclasts | |
| Pain | |
| Palliative Care | |
| Pamidronate | |
| Placebos | |
| Prostatic Neoplasms | |
| Randomized Controlled Trials as Topic | |
| Spinal Cord Compression | |
| United States |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1825515 | Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton. | Oncology | 1991 | https://conductscience.org/library/papers/1825515 | PubMed |
| 2 | 7525038 | Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. | Cancer | 1994 | https://conductscience.org/library/papers/7525038 | PubMed |
| 3 | 7466408 | Treatment of bone metastases. | Semin Oncol | 1980 | https://conductscience.org/library/papers/7466408 | PubMed |
| 4 | 8431928 | Osteoclast inhibition for the treatment of bone metastases. | Cancer Treat Rev | 1993 | https://conductscience.org/library/papers/8431928 | PubMed |
| 5 | 1525054 | Modulation of tumour-induced bone resorption by bisphosphonates. | J Steroid Biochem Mol Biol | 1992 | https://conductscience.org/library/papers/1525054 | PubMed |
| 6 | 1826438 | Treatment of bone metastases from breast cancer and myeloma with pamidronate. | Eur J Cancer | 1991 | https://conductscience.org/library/papers/1826438 | PubMed |
| 7 | 8242577 | New bisphosphonates in the treatment of bone metastases. | Cancer | 1993 | https://conductscience.org/library/papers/8242577 | PubMed |
| 8 | 6692261 | Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy. | Cancer | 1984 | https://conductscience.org/library/papers/6692261 | PubMed |
| 9 | 3514130 | Surgical stabilization of pathological neoplastic fractures. | Curr Probl Cancer | 1986 | https://conductscience.org/library/papers/3514130 | PubMed |
| 10 | 7680374 | Palliative pamidronate treatment in patients with bone metastases from breast cancer. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/7680374 | PubMed |
| 11 | 7532993 | Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects? | Ann Oncol | 1994 | https://conductscience.org/library/papers/7532993 | PubMed |
| 12 | 8471660 | Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications. | Ann Hematol | 1993 | https://conductscience.org/library/papers/8471660 | PubMed |
| 13 | 7532991 | Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer. | Ann Oncol | 1994 | https://conductscience.org/library/papers/7532991 | PubMed |
| 14 | 8418243 | Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/8418243 | PubMed |
| 15 | 7873461 | Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial. | Ann Oncol | 1994 | https://conductscience.org/library/papers/7873461 | PubMed |
| 16 | 7105580 | Mechanisms of lytic and blastic metastatic disease of bone. | Clin Orthop Relat Res | 1982 | https://conductscience.org/library/papers/7105580 | PubMed |
| 17 | 8053405 | Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. | J Bone Miner Res | 1994 | https://conductscience.org/library/papers/8053405 | PubMed |
| 18 | 7873458 | The role of pamidronate. | Ann Oncol | 1994 | https://conductscience.org/library/papers/7873458 | PubMed |
| 19 | 7987173 | Therapeutic use of bisphosphonates in oncology. | BMJ | 1994 | https://conductscience.org/library/papers/7987173 | PubMed |
| 20 | 8150777 | Bisphosphonates in breast cancer patients with skeletal metastases. | Hematol Oncol Clin North Am | 1994 | https://conductscience.org/library/papers/8150777 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12496987 | Ibandronate in the treatment of prostate cancer associated painful osseous metastases. | Prostate Cancer Prostatic Dis | 2002 | https://conductscience.org/library/papers/12496987 | PubMed |
| 12076438 | Bisphosphonates for the relief of pain secondary to bone metastases. | Cochrane Database Syst Rev | 2002 | https://conductscience.org/library/papers/12076438 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8739655
GET https://conductscience.org/api/papers/v1/8739655/references?page=2